2024 HCPCS Code Q5124
Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
| Short Description | Inj. byooviz, 0.1 mg |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2023 |
| HCPCS Code Added Date | April 01, 2022 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q4108 - Integra matrix
- Q4110 - Primatrix
- Q4111 - Gammagraft
- Q4112 - Cymetra injectable
- Q4113 - Graftjacket xpress
- Q4114 - Integra flowable wound matri
- Q4115 - Alloskin
- Q4116 - Alloderm
- Q4117 - Hyalomatrix
- Q4118 - Matristem micromatrix
- Q4119 - Matristem wound matrix
- Q4120 - Matristem burn matrix
- Q4121 - Theraskin
- Q4122 - Dermacell, awm, porous sq cm
- Q4123 - Alloskin
- Q4124 - Oasis tri-layer wound matrix
- Q4125 - Arthroflex
- Q4126 - Memoderm/derma/tranz/integup
- Q4127 - Talymed
- Q4128 - Flexhd/allopatchhd/sq cm